Type 2 Diabetes Trial, Recruiting (NCT06984510)

Type 2 Diabetes Trial, Recruiting NCT06984510 Sponsor: Ningbo No. 1 Hospital Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06984510 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have abdominal ultrasound results available from their annual health check-up records
People who have at least one of the following measurements recorded each year: body weight/waist size (BMI or waist circumference), blood pressure, triglyceride levels, HDL ("good") cholesterol levels, or blood sugar levels (fasting glucose or HbA1c)

Who may not be able to join:

People who are younger than 20 or older than 90 years of age
People whose liver fat has a known cause other than metabolic factors, such as alcohol-related liver disease or hepatitis B infection
People who already had type 2 diabetes at the start of the study period
People who are missing baseline (starting point) results for any of the following blood and health tests: systolic blood pressure, albumin, alkaline phosphatase, blood urea nitrogen, creatinine, HbA1c (long-term blood sugar), total cholesterol, lymphocyte percentage, white blood cell count, mean corpuscular volume, uric acid, fasting blood sugar, and red cell distribution width (RDW)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613486659126

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06984510

Sponsor: Ningbo No. 1 Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: +8613486659126

More information: https://clinicaltrials.gov/study/NCT06984510

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have abdominal ultrasound results available from their annual health check-up records
People who have at least one of the following measurements recorded each year: body weight/waist size (BMI or waist circumference), blood pressure, triglyceride levels, HDL ("good") cholesterol levels, or blood sugar levels (fasting glucose or HbA1c)

Who may not be able to join:

People who are younger than 20 or older than 90 years of age
People whose liver fat has a known cause other than metabolic factors, such as alcohol-related liver disease or hepatitis B infection
People who already had type 2 diabetes at the start of the study period
People who are missing baseline (starting point) results for any of the following blood and health tests: systolic blood pressure, albumin, alkaline phosphatase, blood urea nitrogen, creatinine, HbA1c (long-term blood sugar), total cholesterol, lymphocyte percentage, white blood cell count, mean corpuscular volume, uric acid, fasting blood sugar, and red cell distribution width (RDW)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ningbo No. 1 Hospital

Registry

ClinicalTrials.gov

Start date

1 April 2025

Est. completion

31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of onset T2DM

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov